Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lantmännen AS-Faktor is a Swedish biotechnology company and a subsidiary of the Lantmännen agricultural cooperative, specializing in the research and development of Antisecretory Factor (AF). AF is an endogenous protein that plays a critical role in regulating fluid transport and inflammatory responses across cell membranes. The company commercializes medical foods, such as SPC-Flakes and Salovum, which are designed to induce or provide AF for the treatment of conditions like inflammatory bowel disease, chronic diarrhea, and Ménière's disease. Beyond its commercial portfolio, Lantmännen AS-Faktor is investigating the therapeutic potential of AF-derived peptides, including AF-16, for acute conditions such as traumatic brain injury and respiratory distress.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lantmännen AS Faktor.